Loss of Vitamin A Metabolism in Ovarian Oncogenesis
Loss of Vitamin A Metabolism in Ovarian Oncogenesis
批准号:
7078581
负责人:
THOMAS C. HAMILTON
金额:
$29.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-15 至 2010-04-30
关键词:
DNA damageapoptosiscell cyclecell differentiationcell linecell proliferationepitheliumgene expressiongenetically modified animalshistologyhuman tissueimmunofluorescence techniquelaboratory mouseneoplasm /cancer geneticsneoplastic transformationovaryovary neoplasmsoxidation reduction reactionretinoid binding proteinsretinoidsvitamin metabolismwomen&aposs health
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We recently reported a consistent loss in expression of a protein important for vitamin A homeostasis, cellular retinol-binding protein 1 (CRBP1), in a rat model of ovarian cancer, human ovarian cancer cell lines and in microdissected tumor tissues. This loss was also found in various precursor lesions in prophylactic oophorectomies from women at high risk for breast and ovarian cancer. Moreover, complete loss of vitamin A metabolism was discovered through HPLC analysis in ovarian cancer cells relative to normal ovarian surface epithelium. Such alterations have also been shown in breast cancer. Based on these observations, we hypothesize that concomitant losses of CRBP1 expression and vitamin A metabolism contribute to the etiology of ovarian carcinoma by altering redox and/or differentiation capacity of normal ovarian cells, thus leading to cellular damage conducive to transformation. Our hypothesis will be tested by implementation of the following Specific Aims:
1) Analyze the impact of altered CRBP1 expression and vitamin A homeostasis on ovarian histology and the initiation of ovarian cancer in genetically engineered mice,
2) Determine the impact of CRBP1 expression alteration on the cancer phenotype and ovarian surface epithelial cell transformation, and
3) Determine the impact of altered CRBP1 expression and vitamin A homeostasis on the redox and differentiation status of the ovarian epithelium.
Strategies for addressing the specific aims will focus on in vitro and in vivo evaluation of normal and CRBP1-null mice and then ovarian surface epithelial (MOSE) cells, and CRBP1-inducible human ovarian cell lines. Hopefully, these endeavors will result in a better understanding of ovarian cancer development and progression and provide a basis for more effective prevention of this frequently fatal disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Micro RNA Strategies for Ovarian Cancer
-
批准号:7727493
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2009
-
负责人:THOMAS C. HAMILTON
-
依托单位:
HHMT 10th Biennial International Forum on Ovarian Cancer
-
批准号:6838060
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Loss of Vitamin A Metabolism in Ovarian Oncogenesis
-
批准号:7413334
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2005
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Loss of Vitamin A Metabolism in Ovarian Oncogenesis
-
批准号:7230451
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2005
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Loss of Vitamin A Metabolism in Ovarian Oncogenesis
-
批准号:6966016
-
项目类别:
-
资助金额:$30.05万
-
财政年份:2005
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Loss of Vitamin A Metabolism in Ovarian Oncogenesis
-
批准号:7619658
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2005
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Determination of molecular pathways regulating LOT1 mediated growth suppressions
-
批准号:6667421
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2002
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Career development program
-
批准号:6667429
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2002
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Determination of molecular pathways regulating LOT1 mediated growth suppressions
-
批准号:6504968
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Career development program
-
批准号:6504976
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Career development program
-
批准号:6352806
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2000
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Determination of molecular pathways regulating LOT1 mediated growth suppressions
-
批准号:6352798
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2000
-
负责人:THOMAS C. HAMILTON
-
依托单位:
MOUSE MODELS OF OVARIAN CANCER
-
批准号:6514283
-
项目类别:
-
资助金额:$64.68万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
MOUSE MODELS OF OVARIAN CANCER
-
批准号:6633576
-
项目类别:
-
资助金额:$66.33万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
MOUSE MODELS OF OVARIAN CANCER
-
批准号:6377674
-
项目类别:
-
资助金额:$60.96万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Determination of molecular pathways regulating LOT1 mediated growth suppressions
-
批准号:6323311
-
项目类别:
-
资助金额:$5.43万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Career development program
-
批准号:6323319
-
项目类别:
-
资助金额:$1.01万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
Determination of molecular pathways regulating LOT1 mediated growth suppressions
-
批准号:6230161
-
项目类别:
-
资助金额:$5.43万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
MOUSE MODELS OF OVARIAN CANCER
-
批准号:6175273
-
项目类别:
-
资助金额:$59.25万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
MOUSE MODELS OF OVARIAN CANCER
-
批准号:6038573
-
项目类别:
-
资助金额:$25.55万
-
财政年份:1999
-
负责人:THOMAS C. HAMILTON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: